Buprenorphine: A Simple, Step‑by‑Step Journey Through the Body

Mohamad-Ali Salloum, PharmD • March 7, 2026

Share

  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button
Pharmacology PK/PD

Buprenorphine: A Simple, Step‑by‑Step Journey Through the Body

A clear guide for pharmacy students learning PK/PD the smart way. Short chunks. Visual cues. A quick quiz at the end.

Strong grip = high MOR affinity Weak push = partial agonism
1) Quick History

Where Buprenorphine Came From

Developed in the late 1960s from thebaine(a poppy plant derivative), buprenorphine was designed to give useful opioid effects with a safer profile. It binds very strongly to μ‑opioid receptors (MORs) but only partially activates them.

Opioid Use Disorder (OUD) Chronic Pain (select cases)
2) The Patient

Why Buprenorphine Is Needed

Classic opioid withdrawal may include: runny nose, yawning, dilated pupils, goosebumps, stomach cramps, anxiety, and fast heartbeat — all due to under‑stimulation of MORs.

⚠️
Critical rule: Start buprenorphine only when moderate withdrawal is present. If given too early, it can displace a full agonist and cause precipitated withdrawal.
3) Absorption

How Buprenorphine Enters the Body

Sublingual is the most common route because swallowing leads to extensive first‑pass metabolism. Under the tongue, it reaches systemic circulation directly.

Bioavailability
~30–50% (sublingual)
T max
1–4 hours
Protein binding
~96%
Half‑life
~24–37 hours

Naloxone in combo products has minimal sublingual absorption; it mainly matters if injected.

Hover the button to simulate absorption
4) Distribution

Where the Drug Travels

  • Crosses the blood–brain barrier(high lipophilicity)
  • Accumulates in fat — slow release over time
  • Highly protein‑bound(~96%)
  • Crosses the placenta and appears in breast milk
Memory hook: “Couch‑potato molecule” — likes fat, stays longer.
5) Pharmacodynamics

What the Drug Does

MOR: Partial agonist KOR: Antagonist DOR: Antagonist/weak partial agonist ORL‑1: Partial agonist
Show intracellular actions
  • ↓ cAMP
  • ↓ presynaptic Ca²⁺ → ↓ pain neurotransmitter release
  • ↑ K⁺ efflux → hyperpolarization
Clinical effects: reduces withdrawal and cravings, provides analgesia, ceiling effect on respiratory depression , and functionally blocks other opioids (very high MOR affinity). PET studies suggest ~ 70% MOR occupancy helps suppress withdrawal and block opioid effects.
6) Metabolism

How the Body Breaks It Down

  • Phase I – CYP3A4: buprenorphine → norbuprenorphine (active, poor CNS entry)
  • Phase II – UGT1A1 & UGT2B7: glucuronidation → water‑soluble metabolites
Memory line: “3A4 cuts, UGTs clean.”
CYP3A4 inhibitors ↑ levels CYP3A4 inducers ↓ levels Liver disease: adjust Kidney disease: modest effect
7) Elimination

How It Leaves the Body

  • ~70% via feces (major)
  • ~30% via urine (mostly metabolites)
  • Some enterohepatic recirculation
Memory: “Mostly out the back door.”
8) A → Z Story

One‑Glance Journey (Sublingual Dose)

A. Patient arrives in moderate withdrawal.
B. Sublingual film dissolves → absorbed through oral mucosa.
C. Avoids first‑pass metabolism → enters systemic circulation.
D. Travels in blood (mostly protein‑bound).
E. Free drug crosses into the brain.
F. Strong MOR binding → partial activation.
G. Withdrawal/cravings decrease; ceiling effect improves safety.
H. Liver enzymes break it down (CYP3A4 + UGTs).
I. Metabolites go to bile and kidneys.
Z. Excreted in feces (major) and urine (minor).
9) Key Clinical Tips

High‑Yield for Students

  • Start only in moderate withdrawal to avoid precipitated withdrawal.
  • Typical OUD maintenance: 12–16 mg/day (individualize per labeling/clinical response).
  • Watch CYP3A4 interactions(inhibitors ↑ levels; inducers ↓ levels).
  • CNS depressants increase respiratory risk despite the ceiling.
  • Acute pain is trickier due to receptor blockade — use multimodal strategies.
Check Yourself

Quick Quiz: Can You Recall the Essentials?

1) Why is sublingual buprenorphine preferred over oral swallowing?

2) The best time to start buprenorphine is:

3) Which statement is correct?

4) Main elimination route?

5) Quick metabolism memory aid:


References :


  1. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 13th ed. McGraw‑Hill; 2018. 
  2. Rang HP, Dale MM, Ritter JM, Flower RJ, Henderson G. Rang & Dale’s Pharmacology. 9th ed. Elsevier; 2020. 
  3. Johnson RE, Strain EC, Amass L. Buprenorphine: how to use it right. Drug Alcohol Depend. 2003;70(2 Suppl):S59‑S77. 
  4. SAMHSA. TIP 63: Medications for Opioid Use Disorder. Rockville, MD; 2018. 
  5. Suboxone® (buprenorphine/naloxone) sublingual film. U.S. Prescribing Information. Indivior. 
  6. Kuhlman JJ Jr, et al. Human pharmacokinetics of sublingual buprenorphine. J Anal Toxicol. 1996;20(6):369‑378. 
  7. Rouguieg‑Malki K, et al. Contribution of UGTs and CYP3A4 to buprenorphine metabolism. Drug Metab Dispos. 2011;39(12):2059‑2066. 
  8. Dahan A, et al. Buprenorphine induces ceiling in respiratory depression but not in analgesia. Br J Anaesth. 2006;96(5):627‑632. 
  9. Greenwald MK, et al. Buprenorphine dose, MOR occupancy, and blockade of opioid effects. Neuropsychopharmacology. 2003;28(11):2000‑2009. 
  10. Lund IO, et al. Pregnancy outcomes on buprenorphine vs methadone. Addiction. 2013;108(2):255‑262. 



List of Services

    • Slide title

      Write your caption here
      Button
    • Slide title

      Write your caption here
      Button
    • Slide title

      Write your caption here
      Button
    • Slide title

      Write your caption here
      Button

    ABOUT THE AUTHOR

    Mohamad-Ali Salloum, PharmD

    Mohamad Ali Salloum LinkedIn Profile

    Mohamad-Ali Salloum is a Pharmacist and science writer. He loves simplifying science to the general public and healthcare students through words and illustrations. When he's not working, you can usually find him in the gym, reading a book, or learning a new skill.

    Share

    Recent articles:

    By Mohamad-Ali Salloum, PharmD July 20, 2026
    Learn the science of recovery, why scrolling isn't rest, how sleep repairs the brain, and why weekends alone don't cure burnout.
    By Mohamad-Ali Salloum, PharmD July 18, 2026
    Burnout is more than stress. Learn how chronic burnout impacts mental health, heart health, immunity, cognition, and overall well-being.
    By Mohamad-Ali Salloum, PharmD July 16, 2026
    Burnout doesn’t happen overnight. Learn the early warning signs—mental, physical, and behavioral—so you can catch burnout before it takes control.
    By Mohamad-Ali Salloum, PharmD July 14, 2026
    Feeling exhausted but work isn’t the problem? Learn how life burnout happens and why your daily responsibilities may be draining you.
    By Mohamad-Ali Salloum, PharmD July 12, 2026
    Think burnout is just stress? Discover how your thoughts, habits, and mindset may be silently driving your exhaustion.
    By Mohamad-Ali Salloum, PharmD July 10, 2026
    Why do you feel tired but wired? Explore the science of burnout, from cortisol imbalance and HPA axis dysfunction to brain and nervous system changes caused by chronic stress.
    By Mohamad-Ali Salloum, PharmD July 8, 2026
    Feeling exhausted even after rest? Learn what burnout is, its warning signs, causes, and how it differs from stress and depression. Understand why burnout is increasing and who is most at risk.
    By Mohamad-Ali Salloum, PharmD July 6, 2026
    References: Dhabhar FS. Effects of stress on immune function: the good, the bad, and the beautiful. Immunol Res. 2014;58(2–3):193–210. [link.springer.com] Tang L, Cai N, Zhou Y, et al. Acute stress induces an inflammation dominated by innate immunity represented by neutrophils. Front Immunol. 2022;13:1014296. [pmc.ncbi.nlm.nih.gov] Alotiby A. Immunology of stress: a review article. J Clin Med. 2024;13(21):6394. [mdpi.com] Haykin H, Rolls A. The neuroimmune response during stress: a physiological perspective. Immunity. 2021;54(9):1933–1947. [cell.com] Gutierrez Nunez S, et al. Chronic stress and autoimmunity: the role of HPA axis and cortisol dysregulation. Int J Mol Sci. 2025;26(20):9994. [pmc.ncbi.nlm.nih.gov] Bae YS, Shin EC. Editorial: Stress and immunity. Front Immunol. 2019;10:245. [pmc.ncbi.nlm.nih.gov]
    By Mohamad-Ali Salloum, PharmD July 4, 2026
    Losing motivation to do sports? Read to find out what is happening with you!
    By Mohamad-Ali Salloum, PharmD July 2, 2026
    Losing Motivation to Work? Discover with this Article why is this happening with you!
    More Posts